GC Medical Science Corporation (KOSDAQ:142280)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,425.00
-35.00 (-1.01%)
At close: Jun 10, 2026

GC Medical Science Revenue

GC Medical Science had revenue of 23.55B KRW in the quarter ending March 31, 2026, a decrease of -11.07%. This brings the company's revenue in the last twelve months to 105.48B, down -1.08% year-over-year. In the year 2025, GC Medical Science had annual revenue of 108.41B with 4.39% growth.

Revenue (ttm)
105.48B
Revenue Growth
-1.08%
P/S Ratio
0.71
Revenue / Employee
864.61M
Employees
122
Market Cap
74.47B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025108.41B4.56B4.39%
Dec 31, 2024103.85B9.84B10.47%
Dec 31, 202394.01B-19.10B-16.88%
Dec 31, 2022113.11B11.43B11.25%
Dec 31, 2021101.67B-11.70B-10.32%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Seoulin Bioscience78.58B
Dx & Vx28.48B
Cytogen26.84B
Protia16.25B
HLB Panagene14.64B
3billion11.71B
GENINUS10.24B
Median Diagnostics7.86B
Revenue Rankings